An interventional study of Transfer of Energy Capacitive and Resistive (TECAR) therapy and conventional physical therapy program in Lumbar Radiculopathy, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to male participants aged 35 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
The goal of this clinical trial is to evaluate the effect of Transfer of Energy Capacitive and Resistive (TECAR) on pain, functional disability and electrophysiological parameters in adults with chronic discogenic sciatica . The main questions it aims to answer are:
483 studies on the registry are indexed under Radiculopathy; 145 are open to participants now.
This study's planned enrollment of 34 is below the median of 60 across 373 interventional studies indexed under Radiculopathy.
Browse Radiculopathy studies →Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: Transfer of Energy Capacitive and Resistive (TECAR) therapy · Other: conventional physical therapy program
Other: conventional physical therapy program
* The participant lies prone or side-lying depending on comfort. * Conductive cream is applied to the lumbar region (L4-S1) and gluteal area. * Capacitive mode (CET) will be applied first to target superficial soft tissues. * Resistive mode (RET) will follow to target deeper structures including paraspinal muscles, facet joints, and nerve root pathway. * Each mode will be applied for a predetermined duration (e.g., 10 minutes CET + 10 minutes RET). * Intensity adjusted to produce a deep warm sensation without discomfort. * Total session duration: \~20 minutes treatment program will be delivered in manner of 3 sessions per week for four weeks.
Also known as: TECAR Device (INDIBA® 448 kHz)
conventional physical therapy program will include TENS, hot pack, stretching exercises and core stabilization exercises for 3 sessions per week for four weeks.
Pain intensity
lower back pain will be assessed though Visual Analogue Scale (VAS) which is used to measure the severity of pain. It is a straight line with one end representing no pain and the other end representing the worst imaginable pain. The subject will mark a point on the line that corresponds to the current level of pain he or she experiences. Higher values indicate higher levels of pain while lower values indicate lower levels of pain
Time frame: from enrollment to the end of treatment at 4 weeks
Hoffmann reflex (H-reflex)
H-reflex has been measured in the soleus muscle by stimulating the tibial nerve with a one-millisecond pulse at 0.2pps of H-max. The peak-to-peak amplitude of the highest recorded H-reflex and the latencies of four spaced traces for both lower extremities will be averaged for each participant. lower amplitudes and delayed latencies indicate more damage to nerve root, while higher amplitudes and shorter latencies indicate less damage
Time frame: from enrollment to the end of treatment at 4 weeks
functional disability
Functional disability will be evaluated using the Oswestry Disability Index (ODI), which is considered the gold standard for assessing disability in low back pain and radiculopathy. The ODI consists of 10 sections evaluating daily activities such as lifting, walking, sitting, and personal care. It is scored from 0% to 100%, where higher percentages represent more severe functional impairment
Time frame: from enrollment to the end of treatment at 4 weeks
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.